Invention Grant
- Patent Title: Formulations of an AXL/MER inhibitor
-
Application No.: US16456547Application Date: 2019-06-28
-
Publication No.: US11241438B2Publication Date: 2022-02-08
- Inventor: William L. Rocco , Francis X. Muller
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/53
- IPC: A61K31/53 ; A61P35/00 ; A61K9/20 ; A61K9/48 ; A61K47/12
Abstract:
The present application relates to pharmaceutical formulations and dosage forms of an AXL/MER inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of AXL/MER mediated diseases such as cancer.
Public/Granted literature
- US20200000812A1 FORMULATIONS OF AN AXL/MER INHIBITOR Public/Granted day:2020-01-02
Information query
